The Surgeon General vs the Marlboro Man: Who Really Won?

Slideshow

The images in this slide set are from an exhibition curated by Alan Blum, MD, at the University of Alabama Gorgas Library (November to December 2013) to commemorate the 50th anniversary of the Surgeon General’s Report on Smoking and Health, released on January 11, 1964 by Dr. Luther Terry.

Related Videos
Byoung Chul Cho, MD, PhD, highlights ongoing trials assessing intravenous and subcutaneous amivantamab in EGFR-mutant non–small cell lung cancer.
An AI-based system may reduce the time needed to match patients with cancer to suitable clinical trials.
Surbhi Sidana, MD, an expert on multiple myeloma
A panel of 4 experts on multiple myeloma
A panel of 4 experts on multiple myeloma
A panel of 4 experts on multiple myeloma
A panel of 3 experts on lung cancer
A panel of 3 experts on lung cancer
The use of CT scans may help practices adaptively plan and adjust radiotherapy courses for patients with non–small cell lung cancer.
Patients with NSCLC who have comorbidities or frailty may also be able to receive treatment with fewer toxicities via proton beam radiotherapy.
Related Content
Subgroup findings suggest a PFS benefit with the addition of encorafenib/binimetinib in patients with liver metastases.

Encorafenib Regimen Shows No PFS Improvement in Metastatic BRAF+ Melanoma

Chris Ryan
June 1st 2024
Article

Subgroup findings suggest a PFS benefit with the addition of encorafenib/binimetinib in patients with liver metastases.

Surgical oncologists from Cleveland Clinic discuss the National Accreditation Program for Rectal Cancer and its aim to improve patient outcomes.

Ensuring Quality Rectal Cancer Surgery at NAPRC-Accredited Institutions

Steven Wexner, MD, PhD;Arielle Kanters, MD
May 27th 2024
Podcast

Surgical oncologists from Cleveland Clinic discuss the National Accreditation Program for Rectal Cancer and its aim to improve patient outcomes.

Brentuximab Vedotin Improves Efficacy in Classical Hodgkin Lymphoma

Brentuximab Vedotin Improves Efficacy in Classical Hodgkin Lymphoma

Brielle Benyon
June 1st 2024
Article

Brentuximab vedotin led to unprecedented progression-free survival for patients with classical Hodgkin lymphoma.

Neil M. Iyengar, MD, spoke about the potential impact of exercise on patient-reported outcomes in cancer and achieving work-life balance.

Finding a Place for Exercise Oncology in the Treatment of Breast Cancer

Neil M. Iyengar, MD
May 20th 2024
Podcast

Neil M. Iyengar, MD, spoke about the potential impact of exercise on patient-reported outcomes in cancer and achieving work-life balance.

Post-Hoc OPTIC Results Showcase Continued Safety in CP-CML

Post-Hoc OPTIC Results Showcase Continued Safety in CP-CML

Kristi Rosa
June 1st 2024
Article

Ponatinib remains a safe treatment for patients with chronic-phase chronic myeloid leukemia.

Dabrafenib/Trametinib Yields Sustained Survival During Long-Term Follow-up in Advanced Melanoma

Dabrafenib/Trametinib Yields Sustained Survival During Long-Term Follow-up in Advanced Melanoma

Gina Mauro
June 1st 2024
Article

Continued survival was observed in dabrafenib/trametinib combination after 8 years follow-up in patients with advanced melanoma.